Elinzanetant proved effective for managing disruptive vasomotor symptoms in women on endocrine therapy, supporting a Bayer ...

For women with moderate-to-severe vasomotor symptoms associated with endocrine therapy for hormone receptor (HR)-positive ...

Although rarely used in the US, it may be time to revisit HRT for women with MS, as it eases overlapping symptoms and offers a justifiable benefit-risk profile, experts say.

Research suggests women with high breast cancer risk and menopausal symptoms could benefit from Duavee, which reduced breast tissue cell growth in a Northwestern University study.

Objective: To update and expand The North American Menopause Society’s evidence-based position on nonhormonal management of menopause-associated vasomotor symptoms (VMS), previously a portion of ...

CHICAGO -- The neurokinin-targeted agent elinzanetant significantly reduced the frequency of hot flashes among women ...

Hot flashes happened less often and were less severe in women who took elinzanetant compared to those who took a placebo. The ...

The Scary Menopause Side Effect No One's Talking About first appeared on Parade on May 26, 2025 A surge in cases of a deadly ...

While some of the tell-tale signs of menopause such as night sweats and hot flushes—known as vasomotor symptoms—are well known, many women, like Fadal, don’t recognize the mental health symptoms of ...

VANCOUVER, British Columbia, May 14, 2025--(BUSINESS WIRE)--AbCellera (Nasdaq: ABCL) today announced it has received a No Objection Letter (NOL) from Health Canada authorizing its Clinical Trial ...

“Vasomotor symptoms of menopause affect millions of women, with significant impacts on their well-being, and their personal and professional lives,” said Natalya Nazarenko, MD, Executive ...